Baxter seen mulling $4 bil bid

Investor's Business Daily

The maker of drugs and devices for blood disorders surged 4% to 68.81 after the Wall Street Journal, citing unnamed sources, reported that Baxter (BAX) is in talks to buy Sweden's Gambro for about $4 bil. Baxter makes drugs and devices for disorders of the blood, and Gambro's hemodialysis equipment would fill a hole in its portfolio for hospital-based dialysis, the report said.

View Comments (0)